Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-23 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-10 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-08 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 2e-05 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |